These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 19505813)

  • 1. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of vaccine research and development: tuberculosis.
    Girard MP; Fruth U; Kieny MP
    Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M; Kita Y
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent findings in immunology give tuberculosis vaccines a new boost.
    Kaufmann SH
    Trends Immunol; 2005 Dec; 26(12):660-7. PubMed ID: 16246622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in tuberculosis vaccine development.
    Baumann S; Nasser Eddine A; Kaufmann SH
    Curr Opin Immunol; 2006 Aug; 18(4):438-48. PubMed ID: 16777396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA; Hernández-Pando R; Zumla A
    J Infect Dis; 2009 Mar; 199(5):613-8. PubMed ID: 19199549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future vaccination strategies against tuberculosis: thinking outside the box.
    Kaufmann SH
    Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants in tuberculosis vaccine development.
    Moreno-Mendieta SA; Rocha-Zavaleta L; Rodriguez-Sanoja R
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):75-84. PubMed ID: 20002177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of vaccines against tuberculosis.
    Tyagi AK; Nangpal P; Satchidanandam V
    Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
    Glatman-Freedman A
    Tuberculosis (Edinb); 2006; 86(3-4):191-7. PubMed ID: 16584923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.